A Comparison of Ezetimibe and Evolocumab for Atherogenic Lipid Reduction in Four Patient Populations: A Pooled Efficacy and Safety Analysis of Three Phase 3 Studies

INTRODUCTION: Clinicians, payers, guideline committees, and policymakers support the use of high-intensity statins in patients at high risk for complications of cardiovascular disease (CVD). Guidelines and recommendations provide guidance on next steps for patients with inadequate low-density lipopr...

Descripción completa

Detalles Bibliográficos
Autores principales: Koren, Michael J., Jones, Peter H., Robinson, Jennifer G., Sullivan, David, Cho, Leslie, Hucko, Thomas, Lopez, J. Antonio G., Fleishman, Alex N., Somaratne, Ransi, Stroes, Erik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7584715/
https://www.ncbi.nlm.nih.gov/pubmed/32564340
http://dx.doi.org/10.1007/s40119-020-00181-8

Ejemplares similares

Ejemplares similares